BCL11B and hepatocellular carcinoma: Considering that various other strategies have failed to restore P53 signaling in HCC, our findings provide an alternative way to enhance P53 signaling by inducing the upstream regulator BCL11B, which may have the potential to hinder disease progression and CSC traits in HCC.